AstraZeneca
Company Details
Linkedin ID:
astrazeneca
Website:
Employees number:
76,382
Number of followers:
3,145,950
NAICS:
3254
Industry Type:
Homepage:
astrazeneca.com
IP Addresses:
290
Company ID:
AST_2016061
Scan Status:
Completed
AstraZeneca Company CyberSecurity Posture
astrazeneca.com
We're transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet. For more information, visit www.astrazeneca.com. Community Guidelines: bit.ly/2MgAcio
AstraZeneca A.I CyberSecurity Scoring
AstraZeneca Risk Score (AI oriented)Between 800 and 849
AstraZeneca
Updated:
- Powered by our proprietary A.I cyber incident model
- Insurance preferes TPRM score to calculate premium
AstraZeneca Global Score (TPRM)XXXX
AstraZeneca
- Instant access to detailed risk factors
- Benchmark vs. industry & size peers
- Vulnerabilities
- Findings
AstraZeneca Company CyberSecurity News & History
Past Incidents
1
Attack Types
1
AstraZeneca
Breach
Rankiteo Explanation
Attack limited on finance or reputation
Description: Pharmaceutical giant AstraZeneca suffered a data breach incident after it left a list of credentials online for more than a year that exposed access to sensitive patient data. A developer left the credentials for an AstraZeneca internal server on code-sharing site GitHub in 2021. Credentials, like usernames and passwords, that are exposed or inadvertently published to sites like GitHub
AstraZeneca Company Scoring based on AI Models
Cyber Incidents Likelihood 3 - 6 - 9 months
A.I Risk Score Likelihood 3 - 6 - 9 months
Underwriter Stats for AstraZeneca
Incidents vs Pharmaceutical Manufacturing Industry Average (This Year)
No incidents recorded for AstraZeneca in 2025.
Incidents vs All-Companies Average (This Year)
No incidents recorded for AstraZeneca in 2025.
Incident Types AstraZeneca vs Pharmaceutical Manufacturing Industry Avg (This Year)
No incidents recorded for AstraZeneca in 2025.
Incident History — AstraZeneca (X = Date, Y = Severity)
AstraZeneca cyber incidents detection timeline including parent company and subsidiaries
AstraZeneca Company Subsidiaries
We're transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet. For more information, visit www.astrazeneca.com. Community Guidelines: bit.ly/2MgAcio
Loading...
AstraZeneca Similar Companies
EMS is the leading pharmaceutical company in Brazil. Established since 45 years and with 100% national capital, the company has two industrial plants strategically placed in São Bernardo do Campo and Hortolândia, in the state of São Paulo. With a work based on daring, simplicity, excellence and res
Torrent Pharmaceuticals Ltd
Torrent Pharma, with annual revenues of more than Rs 10,700 crores, is the flagship Company of the Torrent Group, with group revenues of Rs 41,000 crores. It is ranked 5th in the Indian Pharma Market and is among the Top 5 in the therapeutic segments of Cardiovascular (CV), Central Nervous System (C
At Lonza, we enable A Healthier World by supporting our healthcare customers on the path to commercialization. Our community of 16,000 talented employees work across a global network of more than 30 sites to deliver for our customers across the pharma, biotech and nutrition markets. By combining t
Sandoz
Sandoz is the global leader in generic and biosimilar medicines. Our Purpose is to pioneer access to medicines for patients globally. We are on a mission to drive innovation in the healthcare industry by freeing up resources sustainably and responsibly while continuing to address global health c
Servier
Founded to serve health 70 years ago, Servier is a global pharmaceutical group governed by a non-profit Foundation that aspires to make a meaningful social impact for patients and for a sustainable world. The Group’s unique governance model preserves its independence and means it can fully serve its
Catalent
Championing the missions that matter™. Catalent, Inc. is a leading global contract development and manufacturing organization (CDMO) and trusted partner to pharma, biotech, and consumer health companies worldwide. We put patients first in everything we do, helping people live better and healthier li
MSD
At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important
Lupin Limited is a global pharmaceutical leader headquartered in Mumbai, India, with products distributed in over 100 markets. Lupin specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients. Tr
Hyderabad Pharmaceutical Congress Committee
HPCC- Hyderabad pharmaceutical congress committee is an apex body representing Indian pharmacists working in various capacities, viz,pharmaceutical industry,research and development,quality control,quality assurance,academics,drug control departments,hospitals,community and clinical pharmacy,marketi
.png)
AstraZeneca CyberSecurity News
November 24, 2025 02:00 PM
Hyderabad is Emerging as a Bigger GCCs Magnet Than Bengaluru in 2025 – Here’s Why
In this article, we explore a structural shift in 2025, where Hyderabad is outpacing Bengaluru by attracting a larger number of Global...
November 21, 2025 08:07 PM
AstraZeneca Plans $2B Manufacturing Investment In Maryland
New capacity at AstraZeneca's Fredrick and Gaithersburg, Maryland facilities will boost medicine production, create 300 jobs.
November 21, 2025 12:23 PM
IonQ To Present At World Strategic Forum
IonQ, a leading quantum computing company, will present at the 14th World Strategic Forum, showcasing its advancements in quantum...
October 29, 2025 07:00 AM
Building a Zero‑Trust Shield for AI‑Factories and OT Environments
Deloitte collaboration with NVIDIA unlocks the full potential of BlueField-4 for Cyber security.
October 25, 2025 07:00 AM
Advancing data and artificial intelligence
Rapid advancements in artificial intelligence are revolutionising the pharmaceutical industry. Discovery how these advances are changing the...
October 09, 2025 07:00 AM
AstraZeneca Expands U.S. Footprint With $4.5B Virginia Facility
Pharmaceutical giant AstraZeneca plans to invest $4.5 billion in Virginia, the latest industry investment powering economic growth and...
September 19, 2025 07:00 AM
Optimise cyber spend to elevate hospital security
The NHS spent approximately £1.7 billion on cybersecurity and cloud-related IT projects in 2019-2024.1 This blog post, originally published...
July 21, 2025 07:00 AM
AstraZeneca To Invest $50B In U.S. Drug Production, R&D
Virginia facility investment will be AstraZeneca's largest yet. Maryland, Massachusetts, California, Indiana, Texas projects also planned.
June 14, 2025 07:00 AM
Prime Minister suggests AstraZeneca build pharma factory in Vietnam
Vietnam is willing to license AstraZeneca immediately to build vaccine and pharmaceutical factories, said Prime Minister Pham Minh Chinh.
Frequently Asked Questions
Explore insights on cybersecurity incidents, risk posture, and Rankiteo's assessments.
AstraZeneca CyberSecurity History Information
Official Website of AstraZeneca
The official website of AstraZeneca is http://www.astrazeneca.com.
AstraZeneca’s AI-Generated Cybersecurity Score
According to Rankiteo, AstraZeneca’s AI-generated cybersecurity score is 827, reflecting their Good security posture.
How many security badges does AstraZeneca’ have ?
According to Rankiteo, AstraZeneca currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.
Does AstraZeneca have SOC 2 Type 1 certification ?
According to Rankiteo, AstraZeneca is not certified under SOC 2 Type 1.
Does AstraZeneca have SOC 2 Type 2 certification ?
According to Rankiteo, AstraZeneca does not hold a SOC 2 Type 2 certification.
Does AstraZeneca comply with GDPR ?
According to Rankiteo, AstraZeneca is not listed as GDPR compliant.
Does AstraZeneca have PCI DSS certification ?
According to Rankiteo, AstraZeneca does not currently maintain PCI DSS compliance.
Does AstraZeneca comply with HIPAA ?
According to Rankiteo, AstraZeneca is not compliant with HIPAA regulations.
Does AstraZeneca have ISO 27001 certification ?
According to Rankiteo,AstraZeneca is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.
Industry Classification of AstraZeneca
AstraZeneca operates primarily in the Pharmaceutical Manufacturing industry.
Number of Employees at AstraZeneca
AstraZeneca employs approximately 76,382 people worldwide.
Subsidiaries Owned by AstraZeneca
AstraZeneca presently has no subsidiaries across any sectors.
AstraZeneca’s LinkedIn Followers
AstraZeneca’s official LinkedIn profile has approximately 3,145,950 followers.
NAICS Classification of AstraZeneca
AstraZeneca is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.
AstraZeneca’s Presence on Crunchbase
Yes, AstraZeneca has an official profile on Crunchbase, which can be accessed here: https://www.crunchbase.com/organization/astrazeneca.
AstraZeneca’s Presence on LinkedIn
Yes, AstraZeneca maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/astrazeneca.
Cybersecurity Incidents Involving AstraZeneca
As of November 27, 2025, Rankiteo reports that AstraZeneca has experienced 1 cybersecurity incidents.
Number of Peer and Competitor Companies
AstraZeneca has an estimated 5,260 peer or competitor companies worldwide.
What types of cybersecurity incidents have occurred at AstraZeneca ?
Incident Types: The types of cybersecurity incidents that have occurred include Breach.
Incident Details
Can you provide details on each incident ?
Title: AstraZeneca Data Breach
Description: Pharmaceutical giant AstraZeneca suffered a data breach incident after it left a list of credentials online for more than a year that exposed access to sensitive patient data. A developer left the credentials for an AstraZeneca internal server on code-sharing site GitHub in 2021.
Type: Data Breach
Attack Vector: Exposed Credentials
Vulnerability Exploited: Credentials left on GitHub
What are the most common types of attacks the company has faced ?
Common Attack Types: The most common types of attacks the company has faced is Breach.
How does the company identify the attack vectors used in incidents ?
Identification of Attack Vectors: The company identifies the attack vectors used in incidents through GitHub.
Impact of the Incidents
What was the impact of each incident ?
Incident : Data Breach AST2255131222
Data Compromised: Sensitive patient data
Systems Affected: Internal server
What types of data are most commonly compromised in incidents ?
Commonly Compromised Data Types: The types of data most commonly compromised in incidents are Sensitive patient data.
Which entities were affected by each incident ?
Incident : Data Breach AST2255131222
Entity Name: AstraZeneca
Entity Type: Pharmaceutical Company
Industry: Pharmaceuticals
Data Breach Information
What type of data was compromised in each breach ?
Incident : Data Breach AST2255131222
Type of Data Compromised: Sensitive patient data
Sensitivity of Data: High
Initial Access Broker
How did the initial access broker gain entry for each incident ?
Incident : Data Breach AST2255131222
Entry Point: GitHub
Post-Incident Analysis
What were the root causes and corrective actions taken for each incident ?
Incident : Data Breach AST2255131222
Root Causes: Developer error
Additional Questions
Impact of the Incidents
What was the most significant data compromised in an incident ?
Most Significant Data Compromised: The most significant data compromised in an incident was Sensitive patient data.
Data Breach Information
What was the most sensitive data compromised in a breach ?
Most Sensitive Data Compromised: The most sensitive data compromised in a breach was Sensitive patient data.
Initial Access Broker
What was the most recent entry point used by an initial access broker ?
Most Recent Entry Point: The most recent entry point used by an initial access broker was an GitHub.
.png)
Latest Global CVEs (Not Company-Specific)
Description
Angular is a development platform for building mobile and desktop web applications using TypeScript/JavaScript and other languages. Prior to versions 19.2.16, 20.3.14, and 21.0.1, there is a XSRF token leakage via protocol-relative URLs in angular HTTP clients. The vulnerability is a Credential Leak by App Logic that leads to the unauthorized disclosure of the Cross-Site Request Forgery (XSRF) token to an attacker-controlled domain. Angular's HttpClient has a built-in XSRF protection mechanism that works by checking if a request URL starts with a protocol (http:// or https://) to determine if it is cross-origin. If the URL starts with protocol-relative URL (//), it is incorrectly treated as a same-origin request, and the XSRF token is automatically added to the X-XSRF-TOKEN header. This issue has been patched in versions 19.2.16, 20.3.14, and 21.0.1. A workaround for this issue involves avoiding using protocol-relative URLs (URLs starting with //) in HttpClient requests. All backend communication URLs should be hardcoded as relative paths (starting with a single /) or fully qualified, trusted absolute URLs.
Risk Information
cvss4
Base: 7.7
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:N/SC:H/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
References
- https://github.com/angular/angular/commit/0276479e7d0e280e0f8d26fa567d3b7aa97a516f
- https://github.com/angular/angular/commit/05fe6686a97fa0bcd3cf157805b3612033f975bc
- https://github.com/angular/angular/commit/3240d856d942727372a705252f7c8c115394a41e
- https://github.com/angular/angular/releases/tag/19.2.16
- https://github.com/angular/angular/releases/tag/20.3.14
- https://github.com/angular/angular/releases/tag/21.0.1
- https://github.com/angular/angular/security/advisories/GHSA-58c5-g7wp-6w37
Description
Forge (also called `node-forge`) is a native implementation of Transport Layer Security in JavaScript. An Uncontrolled Recursion vulnerability in node-forge versions 1.3.1 and below enables remote, unauthenticated attackers to craft deep ASN.1 structures that trigger unbounded recursive parsing. This leads to a Denial-of-Service (DoS) via stack exhaustion when parsing untrusted DER inputs. This issue has been patched in version 1.3.2.
Risk Information
cvss4
Base: 8.7
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description
Forge (also called `node-forge`) is a native implementation of Transport Layer Security in JavaScript. An Integer Overflow vulnerability in node-forge versions 1.3.1 and below enables remote, unauthenticated attackers to craft ASN.1 structures containing OIDs with oversized arcs. These arcs may be decoded as smaller, trusted OIDs due to 32-bit bitwise truncation, enabling the bypass of downstream OID-based security decisions. This issue has been patched in version 1.3.2.
Risk Information
cvss4
Base: 6.3
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:P/PR:N/UI:N/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description
Suricata is a network IDS, IPS and NSM engine developed by the OISF (Open Information Security Foundation) and the Suricata community. Prior to versions 7.0.13 and 8.0.2, working with large buffers in Lua scripts can lead to a stack overflow. Users of Lua rules and output scripts may be affected when working with large buffers. This includes a rule passing a large buffer to a Lua script. This issue has been patched in versions 7.0.13 and 8.0.2. A workaround for this issue involves disabling Lua rules and output scripts, or making sure limits, such as stream.depth.reassembly and HTTP response body limits (response-body-limit), are set to less than half the stack size.
Risk Information
cvss3
Base: 7.5
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H
Description
Suricata is a network IDS, IPS and NSM engine developed by the OISF (Open Information Security Foundation) and the Suricata community. In versions from 8.0.0 to before 8.0.2, a NULL dereference can occur when the entropy keyword is used in conjunction with base64_data. This issue has been patched in version 8.0.2. A workaround involves disabling rules that use entropy in conjunction with base64_data.
Risk Information
cvss3
Base: 7.5
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H
Access Data Using Our API
Get company history
curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?linkedin_id=astrazeneca' -H 'apikey: YOUR_API_KEY_HERE'
RapidWhat Do We Measure ?
Incident
Finding
Grade
Digital Assets
Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.
These are some of the factors we use to calculate the overall score:
Network Security
Identify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.
SBOM (Software Bill of Materials)
Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.
CMDB (Configuration Management Database)
Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.
Threat Intelligence
Leverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.
Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.
